chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hasn't been able to work; Fever; This spontaneous case was reported by a consumer and describes the occurrence of IMPAIRED WORK ABILITY (Hasn't been able to work) and PYREXIA (Fever) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jul-2021, the patient experienced IMPAIRED WORK ABILITY (Hasn't been able to work) and PYREXIA (Fever). At the time of the report, IMPAIRED WORK ABILITY (Hasn't been able to work) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment information was provided.
+ inches wide at site of shingles vaccination. Extremely swollen, sore to the touch and itchy.  Area under the affected skin is very hard.  As of 7/1 8:12 PM the adverse event is still on going but swelling is reduced.  Treated with Cortisone 10 cream without much success.
Patient received immunizations 8-15-06, Hepatitis B, Tetanus, IPV, MMR.  Grandmother reports child broke out in hives same day of immunization administration and resolved 3 days afterwards.  No welts seen on 8/23/06.  Red raised knot right deltoid at Tetanus site.
Severe hives and rash in the middle of the front of the neck, down to collar, and even on collar bone; Neck itchy; Severe hives and rash in the middle of the front of the neck, down to collar, and even on collar bone; had chills for 6 hours; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Severe hives and rash in the middle of the front of the neck, down to collar, and even on collar bone), PRURITUS (Neck itchy), RASH (Severe hives and rash in the middle of the front of the neck, down to collar, and even on collar bone) and CHILLS (had chills for 6 hours) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Drug allergy. Concomitant products included LOSARTAN, ATORVASTATIN, VITAMIN B NOS and VITAMIN D NOS for an unknown indication.    On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced CHILLS (had chills for 6 hours). On 11-Mar-2021, the patient experienced URTICARIA (Severe hives and rash in the middle of the front of the neck, down to collar, and even on collar bone), PRURITUS (Neck itchy) and RASH (Severe hives and rash in the middle of the front of the neck, down to collar, and even on collar bone). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at an unspecified dose and frequency. On 10-Mar-2021, CHILLS (had chills for 6 hours) had resolved. At the time of the report, URTICARIA (Severe hives and rash in the middle of the front of the neck, down to collar, and even on collar bone), PRURITUS (Neck itchy) and RASH (Severe hives and rash in the middle of the front of the neck, down to collar, and even on collar bone) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: No new information reported
Fever (101 -  102 deg), aches, headache, - flu symptoms. Visited Urgent Care clinic and tested positive for flu.
Four minutes after receiving his vaccination, he developed lightheadedness. He was taken to a private section of the arena  and monitored.
I do not have full range of motion in my left arm. The arm of the injection. I also have a shooting Pain uP my arm into my neck. I have also had exPeriences a migrain
6" diameter area of induration, tenderness at site of Varivax #2 shot 18-48 hours afterward.
Anticipated arm soreness plus severe headache, joint stiffness, chills, and lethargy beginning approximately seven hours after vaccination and worsening over the next 12 hours, with peak severity within 24 hours of injection and lasting approximately 12 hours.
I had a really bad sinus headache and cough. My fever went up to 101 on June 13 Tuesday morning, by 4pm that afternoon it was 99.1. I was having sinus issues prior to my 4th dose and my doctor put me on OTC medications; I go through this every Fall. It got worse after the 4th dose and that Sunday is when it got really bad. When it got really bad with coughing I took the COVID-19 test and it was positive on June 12th. I found out on Monday that my coworkers were positive due to attending a mandatory promotion ceremony 4 days prior. They gave me a Z-PAK on June 22nd.
Fever upt to 105+; shaking spells-not clear of seizure or chills;
I had only a sore arm for the first two vaccines. The third one I had sore arm then the following morning nausea, severe headache, chills fatigue.  I am baffled why the third shot would do this.
Low grade fever, diarrhea and body aches - took tylenol for fever was better 24 hours later
itching; 3 or 4 bumps the size of mosquito bites at the site; 3 or 4 bumps the size of mosquito bites at the site; This case was reported by a consumer via call center representative and described the occurrence of injection site itching in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th October 2019, the patient received the 1st dose of Shingrix. On 28th October 2019, 9 days after receiving Shingrix, the patient experienced injection site itching, injection site rash and injection site papule. On 29th October 2019, the outcome of the injection site itching and injection site rash were recovered/resolved. On an unknown date, the outcome of the injection site papule was recovered/resolved.   It was unknown if the reporter considered the injection site itching, injection site rash and injection site papule to be related to Shingrix.  Additional details were provided as follows: The patient developed itching at the injection site and 3 or 4 bumps the size of mosquito bites at the site that lasted for 1 day and resolved. The reporter consented to follow up.
body aches; stiffness in both hands and fingers/fingers stiffness; This case was reported by a pharmacist via call center representative and described the occurrence of general body pain in a 79-year-old male patient who received Herpes zoster (Shingrix) (batch number 5MHC6EB2X ?, GSK note the reported batch number did not match with any GSK lot number expiry date unknown, ) for prophylaxis.  On 26th December 2019, the patient received the 1st dose of Shingrix. On an unknown date, 3 days after receiving Shingrix, the patient experienced general body pain and limbs stiffness. On an unknown date, the outcome of the general body pain and limbs stiffness were recovered/resolved.   It was unknown if the reporter considered the general body pain and limbs stiffness to be related to Shingrix.  Additional details were provided as follows: The patient reported to the pharmacist that 3 days following the vaccination, he experienced body aches all over his body and stiffness in both hands and fingers of both hands.  The symptoms lasted over a month.
blood pressure was up, at 2 o'clock her BP was 140/98, was down to 123/87 and 124/88; Didn't feel good/felt fuzzy; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE FLUCTUATION (blood pressure was up, at 2 o'clock her BP was 140/98, was down to 123/87 and 124/88) and FEELING ABNORMAL (Didn't feel good/felt fuzzy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051E21A and 020F21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included AMLODIPINE for Blood pressure high.   On 28-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Sep-2021, the patient experienced BLOOD PRESSURE FLUCTUATION (blood pressure was up, at 2 o'clock her BP was 140/98, was down to 123/87 and 124/88) and FEELING ABNORMAL (Didn't feel good/felt fuzzy). At the time of the report, BLOOD PRESSURE FLUCTUATION (blood pressure was up, at 2 o'clock her BP was 140/98, was down to 123/87 and 124/88) and FEELING ABNORMAL (Didn't feel good/felt fuzzy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Sep-2021, Blood pressure measurement: high (High) was up (could not remember the numbers).. On 28-Sep-2021, Blood pressure measurement: 140/98 (High) at 2 o'clock BP was 140/98, 123/87 (High) a little while ago it was down to 123/87 and 124/88 (High) a little while ago it was down to 124/88.         No treatment information was provided by the reporter.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. On 09-OCT-2014, unspecified amount patients were vaccinated with M-M-R II, lot # reported as K002528, expiry date 18-FEB-2016 (dose, route of administration, were not reported) that were improperly stored. No adverse symptom was reported. It was reported that the temperature excursion was unsupported with in-house stability data. This is one of several reports received from the same reproter. Additional information has been requested.
This is a spontaneous report received from contactable consumer or other non-HCP. A female patient received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# unknown), on Apr 6, 2021, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. Vaccination history included the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), for COVID-19 immunisation. The patient developed fatigue/experienced a really bad fatigue, onset Apr 2021, with outcome of unknown. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Headache, Sedation, Myalgia, Arthralgia, Pain at the injection site Narrative:
product=COVID 19 Treatment, brand=Paxlovid/vaccine brand=Pfizer / BioNTech.; product=COVID 19 Treatment, brand=Paxlovid/vaccine brand=Pfizer / BioNTech.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Mar2021 as dose 1, single (Lot number: EN6198), in left arm, on 16Apr2021 as dose 2, single (Lot number: EW0169), in left arm and on 29Oct2021 as dose 3 (booster), single (Lot number: 32030BD) at the age of 51 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 08Apr2022 at 17:00 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Stage zero breast cancer" (unspecified if ongoing); "Penicillin" (unspecified if ongoing); "known allergies: Sulfa drugs" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "product=COVID 19 Treatment, brand=Paxlovid/vaccine brand=Pfizer / BioNTech.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown Results; (31May2022) Negative; (04Jun2022) Positive; (05Jun2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Patient took Tumeric, Gaia, Wellness Formula, Source Naturals from 22May2022 to 25May2022. Patient received Paxlovid from 25May2022 to 29May2022 for COVID-19. After testing negative for Covid since 31May2022 patient tested positive with apparent rebound Covid on 04Jun2022 and continue to test positive 05Jun2022. The antigen test positive test line was bright and immediate. Patient started to get a bit of congestion the evening of 03Jun2022 as well as a headache. When she woke up with chest congestion 04Jun2022 event felt very similar to Covid she took a test and was positive. The chest congestion and cough was worse today. Because she had asthma she started taking Advair at the same time of the medication and a couple days before.
DEVELOPED SIGNIFICANT ERYTHEMA IN THE SHOT SITE ON HER RIGHT THIGH APPROZ 4 TO 5 CM IN DIAMETER
Patient states he can barely move arm, nor can he lift it above his head. He states that he was fine the day of the shot and a couple days after, but then his arm began to ache and this morning he can barely move it.
chills,body aches, fatigue Narrative:  Patient reports chills, body aches, fatigue and shortness of breath 18 hours after his first vaccination that lasted 5 days. He recently has received his second vaccine and has so far tolerated it much better.
This spontaneous report was received from a pharmacist referring to a 70 year old patient of unknown gender. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported. On 06-JUN-2012,  the patient was vaccinated with the first dose of VARIVAX for prophylaxis (route of administration, anatomical location, lot # and expiration date were not reported). On an unknown date (reported as "now"), the patient would like to receive a second dose of VARIVAX. No adverse symptoms were reported.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old male patient received BNT162b2 (BNT162B2), on 08Mar2021 as dose 1, single (Batch/Lot number: unknown) and on 29Mar2021 as dose 2, single (Batch/Lot number: unknown) at the age of 53 years for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 30Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) and on 23Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing), notes: High blood pressure; "Prostate cancer (prostatectomy)" (unspecified if ongoing), notes: Prostate cancer (prostatectomy); "Ulcerative colitis" (unspecified if ongoing); "Prostate cancer" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (22Jul2022) Negative; (27Jul2022) Positive; (30Jul2022) Positive; (unspecified date) Negative; (18Jul2022) Positive. Therapeutic measures were taken as a result of covid-19.  Clinical Course: The patient was did not reported any Seriousness criteria. The Paxlovid treatment start date 18Jul2022 and stop date 22Jul2022 was received. The patient received other medication details was in 2weeks product Spironolactone/Hydrochlorothiazide 25mg/25mg tablet and Mesalamine 1000 mg suppository and Other was used OTC Medications. The started experiencing COVID-19 symptoms on 17Jul while traveling out of state. He went to an urgent care clinic on 18Jul to be tested using PCR, and the doctor prescribed Paxlovid and initial infection resolved within 5 days by the end of the Paxlovid treatment. He tested negative on 22Jul using a home rapid test. He felt fine for the next 4 days and tested negative on 26Jul using a PCR test. On 27Jul I started experiencing symptoms again and took a home rapid test which showed positive. He then had a second "rebound" infection starting on 27Jul. I tested positive today (30Jul) using a home rapid test, and am still feeling sick but my health was improving on adverse event start date 27Jul2022. The AE resulted in None of the above. The patient recovered Recovering and no treatment for AE. The other medical history High blood pressure, Prostate cancer (prostatectomy), Ulcerative colitis and Device Date: 30Jul2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Extreme pressure to both sides of head above ears. Blood Pressure 220/110 (R), 208/124 (L)
Psoriasis; swollen lymph nodes  in neck,ears,face, clavicle; Sore throat; body covered in bumps head to toe; swallowing difficult; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-May-2021 and was forwarded to Moderna on 06-May-2021.    This spontaneous case was reported by a physician and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), RASH PAPULAR (body covered in bumps head to toe), DYSPHAGIA (swallowing difficult), PSORIASIS (Psoriasis) and LYMPHADENOPATHY (swollen lymph nodes  in neck,ears,face, clavicle) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Psoriatic arthritis.    No Medical History information was reported.   On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On 16-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), RASH PAPULAR (body covered in bumps head to toe), DYSPHAGIA (swallowing difficult) and LYMPHADENOPATHY (swollen lymph nodes  in neck,ears,face, clavicle). On an unknown date, the patient experienced PSORIASIS (Psoriasis). At the time of the report, OROPHARYNGEAL PAIN (Sore throat), RASH PAPULAR (body covered in bumps head to toe), DYSPHAGIA (swallowing difficult), PSORIASIS (Psoriasis) and LYMPHADENOPATHY (swollen lymph nodes  in neck,ears,face, clavicle) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
hardness; redness and swelling of the arm; egg allergic patient received FLUZONE vaccine; Initial information received on 25-Oct-2021 regarding an unsolicited valid  non-serious case received from a consumer or non-healthcare professional in the .  This case involves an egg allergic seven years old male patient who experienced redness and swelling of the arm (inflammation) and hardness (induration) while receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT] (contraindication to vaccination).  The patient's past vaccination included INFLUENZA VACCINE.  The patient's medical history, past medical treatment and family history were not provided.  At the time of the event, the patient had ongoing food (egg) allergy.   In 2018, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot UJ087AA and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination (as pediatrician thought kids with egg allergies don't usually react, so FLUZONE was used).  On an unknown date the patient developed a non-serious mild redness and swelling of the arm (inflammation) and hardness (induration) (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  It was case of contraindication to vaccination as egg allergic patient received FLUZONE QUADRIVALENT vaccine (latency: same day).  It was reported ''Caller states that for the past 3 years, her son has had a reaction to his flu vaccine. Each year the vaccine was from a different manufacturer. Mother states that one year, the child received one of the flu vaccines that doesn't contain eggs (not Flublok), but he still reacted. His allergist wants to test the child for sensitivity to each ingredient in all 3 vaccines to determine what he is reacting to. She states that the 2018 FLUZONE administration was the first time he reacted, but it gets worse every time, so that was the mildest symptomatically.''  It was not reported if the patient received a corrective treatment for the events (redness and swelling of the arm, hardness).   Laboratory details were not reported.  On an unknown date, the patient had recovered from inflammation and induration.
Sore arm the night of the vaccine.  Progressed to sore arm, neck and left side of body throughout the night.  Sunday afternoon I could feel a lymph node in the left side of my neck had swollen.  Sunday night I started feeling sensitivity in my left jaw and teeth which progressed to my entire mouth the next day (Monday).  Tuesday the sensitivity was only in the right side of my mouth.  The right side of my mouth, especially my teeth hurt and is extremely sensitive when I drink and eat anything.
The evening following her 1st Moderna dose, she developed a non-itchy rash covering the front and back of her torso up to her chin. No other symptoms of allergy we present (no swelling / respiratory issues). This patient had previously been diagnosed with COVID, and had somewhat more severe flu-like side effects as well 48 hours after vaccination. Since she did not have any other allergy symptoms besides rash, she decided to still receiver her second dose. She took zyrtec to treat her rash, and will take zyrtec immediately following her second dose and stay to be monitored for 30 minutes for allergy symptoms.
3/19/20 - Chest pain 24 hrs after injection. Fever, chills and body aches. 4/2/21 - EXTREME hair loss, lost 3/4 of my hair!!!! (I had a full thick hair prior to the vaccine!)
This spontaneous report as received from a other health professional refers to a patient of unknown age. On an unknown date the patient was vaccinated with VARIVAX for prophylaxis. Concomitant therapies included sterile diluent. On an unknown date the patient experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to VARIVAX. Lot number M045400 is an invalid lot number for VARIVAX. Additional information has been requested.
In the postvaccination observation clinic, the patient complained of new "tightness" in her upper airway. She says that this is similar to reactions to grasses that she has had in past. In past, her symptom has responded completely to diphenhydramine 50 mg PO. No respiratory distress either now or in past. On physical exam, she is not in distress, appears clinically well. A- allergic reaction P- Diphenhydramine 50 mg PO now, given at 12:20 pm. Continued observation x 30 min from the time of medication, with full resolution of symptoms. Discharged.
Short of breath, swelling in limbs, chest pain over the next few weeks. Diagnosed with diastolic dysfunction/congestive heart failure.
Information has been received from a registered nurse concerning an adult patient, on dialysis, who was vaccinated with the primary series of RECOMBIVAX HB in the past (dates unspecified), and now is showing "negative titers". Unspecified medical attention was sought. There was no product quality complaint. At the time of reporting the patient was not yet recovered. Attempts are being made to obtain additional identifying information to distinguish the individual patient mentioned in this report. Additional information will be provided if available. This is one of several reports received from the same source.
Narrative: Pt received vaccination on 10/02/12 per Flu Vaccine Note in database. Additionally, per the note it appears that the patient tolerated the shot well at the time. Writer was unable to find any notes around time of vaccination that indicated that patient had respiratory depression due to vaccine or was hospitalized.